Company Directory / Biopharma
PrivateFor profitBiopharmaSetagaya, Japan
Shaperon is a clinical-stage biotech company that develops inflammasome inhibitors.
Size
11-50 people: larger than 33% of companies with a size listed
Age
18 years old.
Reach
No web traffic ranking listed.
BiopharmaBiotechnology
Funding, as listed
$26B currency not stated
What the source datasets report. We have not watched these rounds ourselves.
Everything the source datasets list about Shaperon, field by field. Contact details are held but never shown.
The company
Where
Size and reach
Funding, as listed
About this record
Growth, as the source summarises it
Shaperon may be growing as it is actively engaging in strategic partnering and institutional investor meetings at a significant healthcare investment conference. This indicates a proactive approach to business development and potential for securing investments or partnerships. The participation in the 10th Annual BFC Healthcare Business Development & Investment Conference in Shanghai suggests that Shaperon is seeking to expand its network and possibly its financial resources. Such activities are typically pursued by companies aiming to accelerate their growth and market presence.
Summaries written by the source dataset, not by us, and not checked.
Biopharma in Japan.
From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 32,492 companies in Japan and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.